UUÂãÁÄÖ±²¥

Legal News

The UK medical devices regime and the impact of the Northern Ireland Protocol

Published on: 11 July 2022

Table of contents

  • Divergence between Great Britain and the EU
  • Key requirements for the GB market
  • Northern Ireland
  • Key differences with the GB regime
  • Issues faced by the UK medical devices industry
  • Areas of potential divergence
  • Impact of the Northern Ireland Protocol Bill
  • Getting ready for the new UKCA regime

Article summary

Life Sciences analysis: Peter Rudd-Clarke, partner, and Anna Lundy, associate director, at Osborne Clarke discuss how the medical device industry is impacted by the Northern Ireland Protocol.

Popular documents